Company Search:
Advanced Search
Sponsored Links
Solasia Pharma KK Company Snapshot
Solasia Pharma KK operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Solasia Pharma KK with three other pharmaceutical manufacturers in Asia: Peptron Inc of KOREA (SOUTH) (2020 sales of 3.12 billion Korean Won [US$2.77 million] of which 54% was Biotechnology), Helixmith Co Ltd of KOREA (SOUTH) (4.30 billion Korean Won [US$3.83 million] of which 436% was Drug Medicine Research and Development), and Pharma Research Bio Co Ltd which is also based in KOREA (SOUTH) (6.31 billion Korean Won [US$5.61 million] ).

Sales Analysis. Solasia Pharma KK reported sales of ¥454.00 million (US$4.16 million) for the year ending December of 2020. This represents a sharp decrease of 65.3% versus 2019, when the company's sales were ¥1.31 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Solasia Pharma KK
  Stock Performance Chart for Solasia Pharma KK
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 139.00
(Figures in Japanese Yen )
1 Week -2.1%   13 Weeks -12.0%  
4 Weeks -2.8%   52 Weeks 3.7%  
Solasia Pharma KK Key Data:
  Ticker: 4597 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 454,000,000
(Year Ending Jan 2021).
Employees: 77
  Currency: Japanese Yen Market Cap: 17,047,128,190
  Fiscal Yr Ends: December Shares Outstanding: 122,641,210
  Share Type: COMMON Closely Held Shares: 42,281,133
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.